Whither Recombinant Human Leptin Treatment for HIV-Associated Lipoatrophy and the Metabolic Syndrome?
Open Access
- 1 April 2009
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (4) , 1089-1091
Abstract
Lipodystrophies are a diverse group of congenital or acquired clinical disorders characterized by a complete or partial lack of adipose tissue (lipoatrophy), anKeywords
This publication has 20 references indexed in Scilit:
- The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and HypoleptinemiaThe Journal of Clinical Endocrinology & Metabolism, 2009
- Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected AdultsNew England Journal of Medicine, 2005
- Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic StrategiesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Human Immunodeficiency Virus Type 1–Related Lipoatrophy and Lipohypertrophy Are Associated with Serum Concentrations of LeptinClinical Infectious Diseases, 2003
- Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral TherapyThe Journal of Clinical Endocrinology & Metabolism, 2003
- Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophyJournal of Clinical Investigation, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine, 2001
- Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapyAIDS, 2001